R - Kim, Kelly Y.
51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
26 °P sammeln
  • Broschiertes Buch

Armed with the notion that R&D collaborations can help accelerate the pace of scientific discovery and innovation, policy makers and program managers have invested a great deal of public resources in new initiatives to facilitate and foster collaborative interactions among academic, private, and governmental entities. However, alliances and collaborations are not always successful, especially when the measure of success extends beyond merely generating new knowledge but getting new products and processes in use by the public. This book presents the results of a research project that examined…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Armed with the notion that R&D collaborations can help accelerate the pace of scientific discovery and innovation, policy makers and program managers have invested a great deal of public resources in new initiatives to facilitate and foster collaborative interactions among academic, private, and governmental entities. However, alliances and collaborations are not always successful, especially when the measure of success extends beyond merely generating new knowledge but getting new products and processes in use by the public. This book presents the results of a research project that examined the impact of research and development R&D collaborations on biomedical product innovation by small biotechnology firms in the U.S., focusing specifically on the impact of partner type.
Autorenporträt
Dr. Kim received her bachelor's in Molecular and Cell Biology from the University of California, Berkeley, and her doctorate in Public Policy, Science and Technology Policy, from The George Washington University, Washington, DC. She is currently a Program Director at the National Cancer Institute in the United States.